Breaking News
Black Friday SALE: Up to 54% off InvestingPro! Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

EXACT Sciences Corporation (EXAS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow EXACT Sciences's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
85.46 -2.63    -2.99%
26/11 - Closed. Currency in USD ( Disclaimer )
After Hours
87.35
+1.89
+2.21%
15:46:43 - Real-time Data
Type:  Equity
Market:  United States
ISIN:  US30063P1057 
CUSIP:  30063P105
  • Volume: 1,318,389
  • Bid/Ask: 85.25 / 87.35
  • Day's Range: 85.03 - 90.39
EXACT Sciences 85.46 -2.63 -2.99%
Latest Release

Nov 02, 2021

EPS / Forecast

-0.97 / -0.8462

Revenue / Forecast

456.38M / 430.03M

Revenue
EPS
 Forecast
 
Release Date Period End EPS /  Forecast Revenue /  Forecast
Feb 24, 2022 12/2021 -- /  -0.9085 -- /  458.58M
Nov 02, 2021 09/2021 -0.97 /  -0.8462 456.38M /  430.03M
Jul 28, 2021 06/2021 -1.03 /  -0.7482 434.82M /  420.98M
May 04, 2021 03/2021 -0.18 /  -0.9636 402.08M /  388.57M
Feb 16, 2021 12/2020 -2.79 /  -0.1936 466.34M /  443.96M
Oct 27, 2020 09/2020 -1.46 /  -0.5357 408.36M /  337.43M
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

EXAS Comments

Write your thoughts about EXACT Sciences Corporation
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Денис Кондраков
Денис Кондраков Nov 01, 2021 11:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
120 go now
Mary Miller
Mary Miller Jul 28, 2021 4:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
For everyone that decided to hold EXAS over night look at the after hours price.
Sccoott Mmaarrt
Sccoott Mmaarrt Jun 24, 2021 8:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The future is now
Michael Stassen
Michael Stassen Feb 25, 2021 8:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Its about the future of medicine
Official Dummy
OfficialDummy Dec 29, 2020 12:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
shiotcoin
Ell Skware
Ell Skware Sep 24, 2020 12:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Congratulations on a good pick ;)
MoneyManager MoneyManager
Money2Manage4U Sep 24, 2020 12:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
they took approval from FDA ?
andrew mccorkle
andrew mccorkle Apr 23, 2020 8:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ohio
Wojciech Stefaniak
Wojciech Stefaniak Jan 17, 2020 3:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lesson 1: don't follow worthless "guru" recommendations! Otherwise you lost your money.
Rita Brattkus
Rita Brattkus Nov 08, 2019 9:23AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bottom! on it's way up...
Steven Miller
Steven Miller Nov 03, 2019 5:24PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think we hit the bottom yesterday.  This looks like a repeat of last year.  The CEO sells stock before the end of the year and the price plummets with the bears and short sellers getting their way.  I suspect we will begin a rebound today or within the week.  Look out for a great short term opportunity between now and 2/20 when the annual and quarterly report come out.  here is usually a run up in the price before the report as they usually beat their estimates.  Price targets are averaging around 58.
Wojciech Stefaniak
Wojciech Stefaniak Oct 30, 2019 12:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$40 again! Back to 2018.
Rita Brattkus
Rita Brattkus May 21, 2019 10:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
excellent product, will not be affected by China trades.
Hamidreza bohlooli
Hamidreza bohlooli Dec 12, 2017 9:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What's happening?
Ryne Siebert
Ryne Siebert Dec 12, 2017 9:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Right?! Haha
Mary Miller
Mary Miller Dec 12, 2017 9:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Liquid biopsy news.Over bought. Will gap back down tomorrow. Already dropping from high today.
Emanuele Marini
Emanuele Marini May 05, 2017 12:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
short at this level, this is not a profitable company.
George Graner
George Graner May 05, 2017 12:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I expect some profit taking today but the reason the company is not profitable is they bought a building last year and spent a fortune on advertising direct to the customer. A smart move because doctors don't like prescribing an at home test that puts their golfing buddies out of a job. This proved very successful and build a prescriber base from 250 to 40,000 growing to 60,000. Now they have a platform to launch a new test for lung cancer with out all the cost. This stock will be $150 in two years.
George Graner
George Graner Mar 03, 2017 3:16PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I started buying options on this stock at $7 and thought it was done at $22. Then they announce a blood test for lung cancer. I'm back in looking at $35.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email